Literature DB >> 16709992

Gabapentin may cause reversible visual field constriction.

Svein Ivar Bekkelund1, Hallvard Lilleng, Stig Tønseth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709992      PMCID: PMC1463919          DOI: 10.1136/bmj.332.7551.1193

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Vigabatrin, tiagabine, and visual fields.

Authors:  M C Lawden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-03       Impact factor: 10.154

2.  Severe persistent visual field constriction associated with vigabatrin.

Authors:  T Eke; J F Talbot; M C Lawden
Journal:  BMJ       Date:  1997-01-18

3.  Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina.

Authors:  G J Sills; P N Patsalos; E Butler; G Forrest; N Ratnaraj; M J Brodie
Journal:  Neurology       Date:  2001-07-24       Impact factor: 9.910

4.  Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects.

Authors:  R Kälviäinen; I Nousiainen; M Mäntyjärvi; E Nikoskelainen; J Partanen; K Partanen; P Riekkinen
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

  4 in total
  4 in total

1.  Gabapentin may cause reversible visual field constriction: learning or inattention artefact a more likely explanation.

Authors:  Tom Eke
Journal:  BMJ       Date:  2006-06-24

2.  Gabapentin may cause reversible visual field constriction: GABA transaminase inhibitors may cause irreversible visual field loss.

Authors:  Jon M Durnian; Louis G Clearkin
Journal:  BMJ       Date:  2006-06-24

3.  Prioritizing children's medicines for research: a pharmaco-epidemiological study of antiepileptic drugs.

Authors:  Ruth Ackers; Macey L Murray; Frank M C Besag; Ian C K Wong
Journal:  Br J Clin Pharmacol       Date:  2007-01-25       Impact factor: 4.335

Review 4.  Review about gabapentin misuse, interactions, contraindications and side effects.

Authors:  Gabriel C Quintero
Journal:  J Exp Pharmacol       Date:  2017-02-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.